Interventional Trials

Interventional Trials

  • Closing the minority gap maximizing ethnic diversity in clinical trials article

    Closing the minority gap maximizing ethnic diversity in clinical trials article

    This topical article examines the role of the CRO in using culturally specific strategies to engage under-represented patient populations, in order to boost trial recruitment.

    View Now
  • Assess The Strength Of Your Evidence Strategy2:00

    Assess The Strength Of Your Evidence Strategy

    See how the Evidence Wisely Assessment Tool can help you assess your readiness for market access. Generate your own unique score and assess strengths & weaknesses of your value demonstration strategy.

    Watch Video
  • Cost-effective safety services for small to mid sized companies

    Get Brochure ►
  • Get your free evidence readiness score today!

    Take Assessment
  • 4 Ways to Align Real-World Data & Stakeholder Needs

    4 Ways to Align Real-World Data & Stakeholder Needs

    Read More
  • Innovative Clinical Trial Designs — Welcomed By Regulators But What About The Payers?

    Innovative Clinical Trial Designs — Welcomed By Regulators But What About The Payers?

    View Now
  • PAREXEL® PRAGMATIC™2:25

    PAREXEL® PRAGMATIC™

    PAREXEL® PRAGMATIC™ helps identify inconsistencies between the purpose of a trial and its actual design, informing better decision-making and operational scoping. The tool helps to design a trial tha

    Watch Video
  • What to look for in a partner to support biosimilar initiatives

    What to look for in a partner to support biosimilar initiatives

    This article looks at some of the trends in biosimilars, including three key errors you need to avoid. Particularly, as it pertains to underestimating your risk management plan.

    View Now
  • ×

    Speak to one of our experts today

    First Name
    Last Name
    Company Name
    Title
    Country
    Comments
    We'll be in touch shortly!
    Error - something went wrong!
  • Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development

    Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development

    Read this presentation to find out more!

    Read More
  • Effective Late Stage Pathways For Biosimilar Products

    Effective Late Stage Pathways For Biosimilar Products

    Read this presentation to find out more!

    Read More
  • Clinical Outcome Assessments Can Help Persuade Payers, If You Select (Or Develop) Them Wisely

    Clinical Outcome Assessments Can Help Persuade Payers, If You Select (Or Develop) Them Wisely

    Learn about how Clinical Outcome Assessments can help persuade payers!

    View Now
  • 3 Important Considerations Of Cardiovascular Outcomes Trials

    3 Important Considerations Of Cardiovascular Outcomes Trials

    When should a cardiovascular outcomes trial be carried out? Find out here!

    View Now
  • ×

    Tell Us About Your Market Access Nightmares.

    What keeps you up at night?
    Thank you!
    Error - something went wrong!
  • A Smarter Database Begins with Smarter Solutions

    A Smarter Database Begins with Smarter Solutions

    Read this case study to find out how PAREXEL can help make enrollment easier through databases!

    View Now
  • loading
    Loading More...